The brain cytokine orchestra in multiple sclerosis: from neuroinflammation to synaptopathology.

Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci. 2019;20(23):6008. https://doi.org/10.3390/ijms20236008 .

doi: 10.3390/ijms20236008 pubmed: 31795299 pmcid: 6929211

Geginat J, Sallusto F, Lanzavecchia A. Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J Exp Med. 2001;194(12):1711–9. https://doi.org/10.1084/jem.194.12.1711 .

doi: 10.1084/jem.194.12.1711 pubmed: 11748273 pmcid: 2193568

Grunnet LG, Aikin R, Tonnesen MF, Paraskevas S, Blaabjerg L, Størling J, et al. Proinflammatory cytokines activate the intrinsic apoptotic pathway in beta-cells. Diabetes. 2009;58(8):1807–15. https://doi.org/10.2337/db08-0178 .

doi: 10.2337/db08-0178 pubmed: 19470609 pmcid: 2712790

Shabab T, Khanabdali R, Moghadamtousi SZ, Kadir HA, Mohan G. Neuroinflammation pathways: a general review. Int J Neurosci. 2017;127(7):624–33. https://doi.org/10.1080/00207454.2016.1212854 .

doi: 10.1080/00207454.2016.1212854 pubmed: 27412492

Schetters STT, Gomez-Nicola D, Garcia-Vallejo JJ, Van Kooyk Y. Neuroinflammation: microglia and T cells get ready to tango. Front Immunol. 2018;25(8):1905. https://doi.org/10.3389/fimmu.2017.01905 .

doi: 10.3389/fimmu.2017.01905

Clark DN, Begg LR, Filiano AJ. Unique aspects of IFN-γ/STAT1 signaling in neurons. Immunol Rev. 2022;311(1):187–204. https://doi.org/10.1111/imr.13092 .

doi: 10.1111/imr.13092 pubmed: 35656941 pmcid: 10120860

Guillery RW. Observations of synaptic structures: origins of the neuron doctrine and its current status. Philos Trans R Soc Lond B Biol Sci. 2005;360:1281–307.

pubmed: 16147523 doi: 10.1098/rstb.2003.1459

Yuste R. From the neuron doctrine to neural networks. Nat Rev Neurosci. 2015;16:487–97.

pubmed: 26152865 doi: 10.1038/nrn3962

Denk W, Briggman K, Helmstaedter M. Structural neurobiology: missing link to a mechanistic understanding of neural computation”. Nat Rev Neurosci. 2012;13:351–8.

pubmed: 22353782 doi: 10.1038/nrn3169

Hof PR, Kidd G, DeFelipe J, de Vellis J, Gama Sosa MA, Elder GA, et al. Cellular components of nervous tissue. In: Byrne JH, Heidelberger R, Waxham MN, editors., et al., From molecules to networks: an introduction to cellular and molecular neuroscience. 3rd ed. Cambridge: Academic Press; 2014. p. 3–21. https://doi.org/10.1016/B978-0-12-397179-1.00001-4 .

doi: 10.1016/B978-0-12-397179-1.00001-4

Bernaus A, Blanco S, Sevilla A. Glia crosstalk in neuroinflammatory diseases. Front Cell Neurosci. 2020;29(14):209.

doi: 10.3389/fncel.2020.00209

Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC. CNS immune privilege: hiding in plain sight. Immunol Rev. 2006;213:48–65. https://doi.org/10.1111/j.1600-065X.2006.00441.x .

doi: 10.1111/j.1600-065X.2006.00441.x pubmed: 16972896 pmcid: 2633103

Marin I, Kipnis J. Learning and memory … and the immune system. Learn Mem. 2013;20:601–6.

pubmed: 24051097 pmcid: 3768198 doi: 10.1101/lm.028357.112

Shechter R, London A, Schwartz M. Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates. Nat Rev Immunol. 2013;13:206–18.

pubmed: 23435332 doi: 10.1038/nri3391

Aspelund A, Antila S, Proulx ST, Karlsen TV, Karaman S, Detmar M, Wiig H, Alitalo K. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med. 2015;212(7):991–9.

pubmed: 26077718 pmcid: 4493418 doi: 10.1084/jem.20142290

Tracey K. Reflex control of immunity. Nat Rev Immunol. 2009;9:418–28.

pubmed: 19461672 pmcid: 4535331 doi: 10.1038/nri2566

Dantzer R. Neuroimmune interactions: from the brain to the immune system and vice versa. Physiol Rev. 2018;98:477–504.

pubmed: 29351513 doi: 10.1152/physrev.00039.2016

Sawada M, Suzumura A, Marunouchi T. Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells. Int J Dev Neurosci. 1995;13:253–64.

pubmed: 7572279 pmcid: 7135063 doi: 10.1016/0736-5748(94)00076-F

Heinisch S, Kirby LG. SDF-1alpha/CXCL12 enhances GABA and glutamate synaptic activity at serotonin neurons in the rat dorsal raphe nucleus. Neuropharmacology. 2010;58(2):501–14.

pubmed: 19755127 doi: 10.1016/j.neuropharm.2009.08.022

Louveau A, Harris TH, Kipnis J. Revisiting the mechanisms of CNS immune privilege. Trends Immunol. 2015;36:569–77.

pubmed: 26431936 pmcid: 4593064 doi: 10.1016/j.it.2015.08.006

McAfoose J, Baune BT. Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev. 2009;33(3):355–66.

pubmed: 18996146 doi: 10.1016/j.neubiorev.2008.10.005

Nisticò R, Salter E, Nicolas C, Feligioni M, Mango D, Bortolotto ZA, Gressens P, Collingridge GL, Peineau S. Synaptoimmunology—roles in health and disease. Mol Brain. 2017;10(1):26.

pubmed: 28637489 pmcid: 5480158 doi: 10.1186/s13041-017-0308-9

Depino AM, Alonso M, Ferrari C, del Rey A, Anthony D, Besedovsky H, Medina JH, Pitossi F. Learning modulation by endogenous hippocampal IL-1: blockade of endogenous IL-1 facilitates memory formation. Hippocampus. 2004;14(4):526–35. https://doi.org/10.1002/hipo.10164 .

doi: 10.1002/hipo.10164 pubmed: 15224987

Stellwagen D, Malenka R. Synaptic scaling mediated by glial TNF-α. Nature. 2006;440:1054–9.

pubmed: 16547515 doi: 10.1038/nature04671

Santello M, Volterra A. TNFα in synaptic function: switching gears. Trends Neurosci. 2012;35(10):638–47.

pubmed: 22749718 doi: 10.1016/j.tins.2012.06.001

Vezzani A, Viviani B. Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology. 2015;96:70–82.

pubmed: 25445483 doi: 10.1016/j.neuropharm.2014.10.027

Falcicchia C, Tozzi F, Arancio O, Watterson DM, Origlia N. Involvement of p38 MAPK in synaptic function and dysfunction. Int J Mol Sci. 2020;21(16):5624.

pubmed: 32781522 pmcid: 7460549 doi: 10.3390/ijms21165624

Bodnar CN, Morganti JM, Bachstetter AD. Depression following a traumatic brain injury: uncovering cytokine dysregulation as a pathogenic mechanism. Neural Regen Res. 2018;13(10):1693–704.

pubmed: 30136679 pmcid: 6128046 doi: 10.4103/1673-5374.238604

Wang S, Cheng Q, Malik S, Yang J. Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. J Pharmacol Exp Ther. 2000;292(2):497–504.

pubmed: 10640285

Pribiag H, Stellwagen D. TNF-α downregulates inhibitory neurotransmission through protein phosphatase 1-dependent trafficking of GABA(A) receptors. J Neurosci. 2013;33(40):15879–93.

pubmed: 24089494 pmcid: 6618471 doi: 10.1523/JNEUROSCI.0530-13.2013

Giacco V, Panattoni G, Medelin M, Bonechi E, Aldinucci A, Ballerini C, et al. Cytokine inflammatory threat, but not LPS one, shortens GABAergic synaptic currents in the mouse spinal cord organotypic cultures. J Neuroinflammation. 2019;16(1):127. https://doi.org/10.1186/s12974-019-1519-z .

doi: 10.1186/s12974-019-1519-z pubmed: 31238967 pmcid: 6593520

Ren S, Breuillaud L, Yao W, Yin T, Norris KA, Zehntner SP, D’Adamio L. TNF-α-mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer’s disease pathology in young Trem2R47H rats. J Biol Chem. 2021;296:100089.

pubmed: 33434745 doi: 10.1074/jbc.RA120.016395

Stellwagen D, Beattie EC, Seo JY, Malenka RC. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci. 2005;25(12):3219–28.

pubmed: 15788779 pmcid: 6725093 doi: 10.1523/JNEUROSCI.4486-04.2005

Van Den Bosch L, Van Damme P, Bogaert E, Robberecht W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta. 2006;1762(11–12):1068–82.

pubmed: 16806844 doi: 10.1016/j.bbadis.2006.05.002

Schäfers M, Sorkin L. Effect of cytokines on neuronal excitability. Neurosci Lett. 2008;437(3):188–93.

pubmed: 18420346 doi: 10.1016/j.neulet.2008.03.052

Sitcheran R, Gupta P, Fisher PB, Baldwin AS. Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNFalpha-controlled repression. EMBO J. 2005;24(3):510–20.

pubmed: 15660126 pmcid: 548660 doi: 10.1038/sj.emboj.7600555

Hu S, Sheng WS, Ehrlich LC, Peterson PK, Chao CC. Cytokine effects on glutamate uptake by human astrocytes. NeuroImmunoModulation. 2000;7(3):153–9.

pubmed: 10754403 doi: 10.1159/000026433

Henstridge CM, Tzioras M, Paolicelli RC. Glial contribution to excitatory and inhibitory synapse loss in neurodegeneration. Front Cell Neurosci. 2019;26(13):63.

doi: 10.3389/fncel.2019.00063

Mizuno T, Zhang G, Takeuchi H, Kawanokuchi J, Wang J, Sonobe Y, Jin S, Takada N, Komatsu Y, Suzumura A. Interferon-gamma directly induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN-gamma receptor and AMPA GluR1 receptor. FASEB J. 2008;22(6):1797–806.

pubmed: 18198214 doi: 10.1096/fj.07-099499

Becher B, Spath S, Goverman J. Cytokine networks in neuroinflammation. Nat Rev Immunol. 2017;17(1):49–59.

pubmed: 27916979 doi: 10.1038/nri.2016.123

Daneman R, Prat A. The blood-brain barrier. Cold Spring Harb Perspect Biol. 2015;7(1): a020412. https://doi.org/10.1101/cshperspect.a020412 .

doi: 10.1101/cshperspect.a020412 pubmed: 25561720 pmcid: 4292164

Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005;57(2):173–85. https://doi.org/10.1124/pr.57.2.4 .

doi: 10.1124/pr.57.2.4 pubmed: 15914466

Engelhardt B, Ransohoff RM. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 2005;26(9):485–95. https://doi.org/10.1016/j.it.2005.07.004 .

doi: 10.1016/j.it.2005.07.004 pubmed: 16039904

Alvarez JI, Teale JM. Multiple expression of matrix metalloproteinases in murine neurocysticercosis: Implications for leukocyte migration through multiple central nervous system barriers. Brain Res. 2008;1214:145–58.

pubmed: 18466882 pmcid: 2517245 doi: 10.1016/j.brainres.2008.03.036

Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med. 2013;19(12):1584–96. https://doi.org/10.1038/nm.3407 .

doi: 10.1038/nm.3407 pubmed: 24309662 pmcid: 4080800

Wilson EH, Weninger W, Hunter CA. Trafficking of immune cells in the central nervous system. J Clin Invest. 2010;120(5):1368–79. https://doi.org/10.1172/JCI41911 .

doi: 10.1172/JCI41911 pubmed: 20440079 pmcid: 2860945

Kivisäkk P, Mahad DJ, Callahan MK, Trebst C, Tucky B, Wei T, et al. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci USA. 2003;100(14):8389–94. https://doi.org/10.1073/pnas.1433000100 .

doi: 10.1073/pnas.1433000100 pubmed: 12829791 pmcid: 166239

Haegele KF, Stueckle CA, Malin JP, Sindern E. Increase of CD8+ T-effector memory cells in peripheral blood of patients with relapsing-remitting multiple sclerosis compared to healthy controls. J Neuroimmunol. 2007;183(1–2):168–74. https://doi.org/10.1016/j.jneuroim.2006.09.008 .

doi: 10.1016/j.jneuroim.2006.09.008 pubmed: 17084910

Ransohoff RM, Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol. 2012;12(9):623–35. https://doi.org/10.1038/nri3265 .

doi: 10.1038/nri3265 pubmed: 22903150

Croese T, Castellani G, Schwartz M. Immune cell compartmentalization for brain surveillance and protection. Nat Immunol. 2021;22(9):1083–92. https://doi.org/10.1038/s41590-021-00994-2 .

doi: 10.1038/s41590-021-00994-2 pubmed: 34429552

Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S, et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol. 2009;10(5):514–23. https://doi.org/10.1038/ni.1716 .

doi: 10.1038/ni.1716 pubmed: 19305396

Smolders J, Remmerswaal EB, Schuurman KG, Melief J, van Eden CG, van Lier RA, et al. Characteristics of differentiated CD8(+) and CD4 (+) T cells present in the human brain. Acta Neuropathol. 2013;126(4):525–35. https://doi.org/10.1007/s00401-013-1155-0 .

doi: 10.1007/s00401-013-1155-0 pubmed: 23880787

Brynskikh A, Warren T, Zhu J, Kipnis J. Adaptive immunity affects learning behavior in mice. Brain Behav Immun. 2008;22(6):861–9. https://doi.org/10.1016/j.bbi.2007.12.008 .

doi: 10.1016/j.bbi.2007.12.008 pubmed: 18249087

Filiano AJ, Gadani SP, Kipnis J. How and why do T cells and their derived cytokines affect the injured and healthy brain? Nat Rev Neurosci. 2017;18(6):375–84. https://doi.org/10.1038/nrn.2017.39 .

doi: 10.1038/nrn.2017.39 pubmed: 28446786 pmcid: 5823005

Derecki NC, Cardani AN, Yang CH, Quinnies KM, Crihfield A, Lynch KR, Kipnis J. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med. 2010;207(5):1067–80. https://doi.org/10.1084/jem.20091419 .

doi: 10.1084/jem.20091419 pubmed: 20439540 pmcid: 2867291

Ribeiro M, Brigas HC, Temido-Ferreira M, Pousinha PA, Regen T, Santa C, et al. Meningeal γδ T cell-derived IL-17 controls synaptic plasticity and short-term memory. Sci Immunol. 2019;4(40):eaay5199. https://doi.org/10.1126/sciimmunol.aay5199 .

doi: 10.1126/sciimmunol.aay5199 pubmed: 31604844 pmcid: 6894940

de Lima KA, Rustenhoven J, Da Mesquita S, Wall M, Salvador AF, Smirnov I, et al. Meningeal γδ T cells regulate anxiety-like behavior via IL-17a signaling in neurons. Nat Immunol. 2020;21(11):1421–9. https://doi.org/10.1038/s41590-020-0776-4 .

doi: 10.1038/s41590-020-0776-4 pmcid: 8496952

Kipnis J, Cohen H, Cardon M, Ziv Y, Schwartz M. T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. Proc Natl Acad Sci USA. 2004;101(21):8180–5. https://doi.org/10.1073/pnas.0402268101 .

doi: 10.1073/pnas.0402268101 pubmed: 15141078 pmcid: 419577

Kerfoot SM, Norman MU, Lapointe BM, Bonder CS, Zbytnuik L, Kubes P. Reevaluation of P-selectin and alpha 4 integrin as targets for the treatment of experimental autoimmune encephalomyelitis. J Immunol. 2006;176(10):6225–34. https://doi.org/10.4049/jimmunol.176.10.6225 .

doi: 10.4049/jimmunol.176.10.6225 pubmed: 16670333

Wolburg K, Gerhardt H, Schulz M, Wolburg H, Engelhardt B. Ultrastructural localization of adhesion molecules in the healthy and inflamed choroid plexus of the mouse. Cell Tissue Res. 1999;296(2):259–69.

pubmed: 10382270 doi: 10.1007/s004410051287

Bove R, Chitnis T. Sexual disparities in the incidence and course of MS. Clin Immunol. 2013;149(2):201–10. https://doi.org/10.1016/j.clim.2013.03.005 .

doi: 10.1016/j.clim.2013.03.005 pubmed: 23608496

Ghasemi N, Razavi S, Nikzad E. Multiple sclerosis: pathogenesis, symptoms. Diagn Cell-Based Therapy Cell J. 2017;19(1):1–10. https://doi.org/10.22074/cellj.2016.4867 .

doi: 10.22074/cellj.2016.4867

Dempsey LA. Molecular mimicry in MS. Nat Immunol. 2022;23(3):343. https://doi.org/10.1038/s41590-022-01156-8 .

doi: 10.1038/s41590-022-01156-8 pubmed: 35236961

Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375(6578):296–301. https://doi.org/10.1126/science.abj8222 .

doi: 10.1126/science.abj8222 pubmed: 35025605

Kaskow BJ, Baecher-Allan C. Effector T cells in multiple sclerosis. Cold Spring Harb Perspect Med. 2018;8(4): a029025. https://doi.org/10.1101/cshperspect.a029025 .

doi: 10.1101/cshperspect.a029025 pubmed: 29358315 pmcid: 5880159

Salou M, Nicol B, Garcia A, Laplaud DA. Involvement of CD8(+) T Cells in multiple sclerosis. Front Immunol. 2015;6:604. https://doi.org/10.3389/fimmu.2015.00604 .

doi: 10.3389/fimmu.2015.00604 pubmed: 26635816 pmcid: 4659893

Battistini L, Piccio L, Rossi B, Bach S, Galgani S, Gasperini C, et al. CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1. Blood. 2003;101(12):4775–82. https://doi.org/10.1182/blood-2002-10-3309 .

doi: 10.1182/blood-2002-10-3309 pubmed: 12595306

Lucchinetti CF, Popescu BFG, Bunyan RF, Moll NM, Roemer SF, Lassmann H, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med. 2011;365:2188–97. https://doi.org/10.1056/NEJMoa1100648 .

doi: 10.1056/NEJMoa1100648 pubmed: 22150037 pmcid: 3282172

Karpus WJ. Cytokines and chemokines in the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol. 2020;204(2):316–26. https://doi.org/10.4049/jimmunol.1900914 .

doi: 10.4049/jimmunol.1900914 pubmed: 31907274

Robinson AP, Harp CT, Noronha A, Miller SD. The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handb Clin Neurol. 2014;122:173–89. https://doi.org/10.1016/B978-0-444-52001-2.00008-X .

doi: 10.1016/B978-0-444-52001-2.00008-X pubmed: 24507518 pmcid: 3981554

Ben-Nun A, Wekerle H, Cohen IR. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol. 1981;11:195–9.

pubmed: 6165588 doi: 10.1002/eji.1830110307

Marchetti L, Engelhardt B. Immune cell trafficking across the blood-brain barrier in the absence and presence of neuroinflammation. Vasc Biol. 2020;2(1):H1–18. https://doi.org/10.1530/VB-19-0033 .

doi: 10.1530/VB-19-0033 pubmed: 32923970 pmcid: 7439848

Brambilla R, Morton PD, Ashbaugh JJ, Karmally S, Lambertsen KL, Bethea JR. Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination. Glia. 2014;62(3):452–67. https://doi.org/10.1002/glia.22616 .

doi: 10.1002/glia.22616 pubmed: 24357067

Laschinger M, Vajkoczy P, Engelhardt B. Encephalitogenic T cells use LFA-1 for transendothelial migration but not during capture and initial adhesion strengthening in healthy spinal cord microvessels in vivo. Eur J Immunol. 2002;32:3598–606. https://doi.org/10.1002/1521-4141(200212)32:12%3c3598::AIDIMMU3598%3e3.0.CO;2-6 .

doi: 10.1002/1521-4141(200212)32:12<3598::AIDIMMU3598>3.0.CO;2-6 pubmed: 12516546

Carrithers MD, Visintin I, Kang SJ, Janeway CA Jr. Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment. Brain. 2000;123:1092–101. https://doi.org/10.1093/brain/123.6.1092 .

doi: 10.1093/brain/123.6.1092 pubmed: 10825349

Song X, Gao H, Qian Y. Th17 differentiation and their pro-inflammation function. Adv Exp Med Biol. 2014;841:99–151. https://doi.org/10.1007/978-94-017-9487-9_5 .

doi: 10.1007/978-94-017-9487-9_5 pubmed: 25261206

Domingues HS, Mues M, Lassmann H, Wekerle H, Krishnamoorthy G. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PLoS ONE. 2010;5(11): e15531. https://doi.org/10.1371/journal.pone.0015531 .

doi: 10.1371/journal.pone.0015531 pubmed: 21209700 pmcid: 3000428

Alt C, Laschinger M, Engelhardt B. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the bloodbrain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis. Eur J Immunol. 2002;32:2133–44. https://doi.org/10.1002/1521-4141(200208)32:8%3c2133::AID-IMMU2133%3e3.0.CO;2-W .

doi: 10.1002/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO;2-W pubmed: 12209625

Krumbholz M, Theil D, Steinmeyer F, Cepok S, Hemmer B, Hofbauer M, et al. CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions. J Neuroimmunol. 2007;190:72–9. https://doi.org/10.1016/j.jneuroim.2007.07.024 .

doi: 10.1016/j.jneuroim.2007.07.024 pubmed: 17825430

Vajkoczy P, Laschinger M, Engelhardt B. Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J Clin Investig. 2001;108:557–65. https://doi.org/10.1172/JCI12440 .

doi: 10.1172/JCI12440 pubmed: 11518729 pmcid: 209399

Steffen BJ, Butcher EC, Engelhardt B. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am J Pathol. 1994;145(1):189–201.

pubmed: 7518194 pmcid: 1887301

Glatigny S, Duhen R, Oukka M, Bettelli E. Cutting edge: loss of α4 integrin expression differentially affects the homing of Th1 and Th17 cells. J Immunol. 2011;187(12):6176–9. https://doi.org/10.4049/jimmunol.1102515 .

doi: 10.4049/jimmunol.1102515 pubmed: 22084440

Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L, et al. Mice with a disrupted IFNgamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol. 1996;156:5–7.

pubmed: 8598493 doi: 10.4049/jimmunol.156.1.5

Willenborg DO, Fordham S, Bernard CC, Cowden WB, Ramshaw IA. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol. 1996;157:3223–7.

pubmed: 8871615 doi: 10.4049/jimmunol.157.8.3223

Sosa RA, Murphey C, Robinson RR, Forsthuber TG. IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation. Proc Natl Acad Sci USA. 2015;112(36):E5038–47. https://doi.org/10.1073/pnas.1505955112 .

doi: 10.1073/pnas.1505955112 pubmed: 26305941 pmcid: 4568689

White MPJ, Webster G, Leonard F, La Flamme AC. Innate IFN-γ ameliorates experimental autoimmune encephalomyelitis and promotes myeloid expansion and PDL-1 expression. Sci Rep. 2018;8(1):259. https://doi.org/10.1038/s41598-017-18543-z .

doi: 10.1038/s41598-017-18543-z pubmed: 29321652 pmcid: 5762891

Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13(5):715–25. https://doi.org/10.1016/s1074-7613(00)00070-4 .

doi: 10.1016/s1074-7613(00)00070-4 pubmed: 11114383

Segal BM, Dwyer BK, Shevach EM. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med. 1998;187(4):537–46. https://doi.org/10.1084/jem.187.4.537 .

doi: 10.1084/jem.187.4.537 pubmed: 9463404 pmcid: 2212155

Gran B, Zhang GX, Yu S, Li J, Chen XH, Ventura ES, et al. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J Immunol. 2002;169(12):7104–10. https://doi.org/10.4049/jimmunol.169.12.7104 .

doi: 10.4049/jimmunol.169.12.7104 pubmed: 12471147

Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 2003;421(6924):744–8. https://doi.org/10.1038/nature01355 .

doi: 10.1038/nature01355 pubmed: 12610626

Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med. 2003;198(12):1951–7. https://doi.org/10.1084/jem.20030896 .

doi: 10.1084/jem.20030896 pubmed: 14662908 pmcid: 2194162

Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ, Konkel JE, et al. Generation of pathogenic T(H)17 cells in the absence of TGFβ signalling. Nature. 2010;467(7318):967–71. https://doi.org/10.1038/nature09447 .

doi: 10.1038/nature09447 pubmed: 20962846 pmcid: 3108066

McGeachy MJ, Chen Y, Tato CM, Laurence A, Joyce-Shaikh B, Blumenschein WM, et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol. 2009;10(3):314–24. https://doi.org/10.1038/ni.1698 .

doi: 10.1038/ni.1698 pubmed: 19182808 pmcid: 2945605

Andreadou M, Ingelfinger F, De Feo D, Cramer TLM, Tuzlak S, Friebel E, et al. IL-12 sensing in neurons induces neuroprotective CNS tissue adaptation and attenuates neuroinflammation in mice. Nat Neurosci. 2023;26(10):1701–12. https://doi.org/10.1038/s41593-023-01435-z .

doi: 10.1038/s41593-023-01435-z pubmed: 37749256 pmcid: 10545539

McQualter JL, Darwiche R, Ewing C, Onuki M, Kay TW, Hamilton JA, et al. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J Exp Med. 2001;194(7):873–82. https://doi.org/10.1084/jem.194.7.873 .

doi: 10.1084/jem.194.7.873 pubmed: 11581310 pmcid: 2193476

Croxford AL, Lanzinger M, Hartmann FJ, Schreiner B, Mair F, Pelczar P, et al. The cytokine GM-CSF drives the inflammatory signature of CCR2+ monocytes and licenses autoimmunity. Immunity. 2015;43(3):502–14. https://doi.org/10.1016/j.immuni.2015.08.010 .

doi: 10.1016/j.immuni.2015.08.010 pubmed: 26341401

Ponomarev ED, Shriver LP, Maresz K, Pedras-Vasconcelos J, Verthelyi D, Dittel BN. GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. J Immunol. 2007;178(1):39–48. https://doi.org/10.4049/jimmunol.178.1.39 .

doi: 10.4049/jimmunol.178.1.39 pubmed: 17182538

Matejuk A, Dwyer J, Ito A, Bruender Z, Vandenbark AA, Offner H. Effects of cytokine deficiency on chemokine expression in CNS of mice with EAE. J Neurosci Res. 2002;67(5):680–8. https://doi.org/10.1002/jnr.10156 .

doi: 10.1002/jnr.10156 pubmed: 11891780

Mandolesi G, Gentile A, Musella A, Centonze D. IL-1β dependent cerebellar synaptopathy in a mouse mode of multiple sclerosis. Cerebellum. 2015;14(1):19–22.

pubmed: 25326653 doi: 10.1007/s12311-014-0613-0

Rizzo FR, Musella A, De Vito F, Fresegna D, Bullitta S, Vanni V, et al. Tumor necrosis factor and interleukin-1β modulate synaptic plasticity during neuroinflammation. Neural Plast. 2018;14(2018):8430123.

Di Filippo M, Portaccio E, Mancini A, Calabresi P. Multiple sclerosis and cognition: synaptic failure and network dysfunction. Nat Rev Neurosci. 2018;19(10):599–609. https://doi.org/10.1038/s41583-018-0053-9 .

doi: 10.1038/s41583-018-0053-9 pubmed: 30158590

Vercellino M, Marasciulo S, Grifoni S, Vallino-Costassa E, Bosa C, Pasanisi MB, et al. Acute and chronic synaptic pathology in multiple sclerosis gray matter. Mult Scler. 2022;28(3):369–82.

pubmed: 34124960 doi: 10.1177/13524585211022174

Centonze D, Muzio L, Rossi S, Cavasinni F, De Chiara V, Bergami A, et al. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci. 2009;29(11):3442–52. https://doi.org/10.1523/JNEUROSCI.5804-08.2009 .

doi: 10.1523/JNEUROSCI.5804-08.2009 pubmed: 19295150 pmcid: 6665268

van der Valk P, Amor S. Preactive lesions in multiple sclerosis. Curr Opin Neurol. 2009;22(3):207–13.

pubmed: 19417567 doi: 10.1097/WCO.0b013e32832b4c76

Jafari M, Schumacher AM, Snaidero N, Ullrich Gavilanes EM, Neziraj T, Kocsis-Jutka V, et al. Phagocyte-mediated synapse removal in cortical neuroinflammation is promoted by local calcium accumulation. Nat Neurosci. 2021;24(3):355–67.

pubmed: 33495636 doi: 10.1038/s41593-020-00780-7

Rossi S, Furlan R, De Chiara V, Motta C, Studer V, Mori F, et al. Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis. Ann Neurol. 2012;71(1):76–83.

pubmed: 22275254 doi: 10.1002/ana.22512

Musumeci G, Grasselli G, Rossi S, De Chiara V, Musella A, Motta C, et al. Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis. Neurobiol Dis. 2011;43(3):669–77.

pubmed: 21672630 doi: 10.1016/j.nbd.2011.05.018

Bellingacci L, Mancini A, Gaetani L, Tozzi A, Parnetti L, Di Filippo M. Synaptic dysfunction in multiple sclerosis: a red thread from inflammation to network disconnection. Int J Mol Sci. 2021;22(18):9753.

pubmed: 34575917 pmcid: 8469646 doi: 10.3390/ijms22189753

Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity. 2009;31(2):331–41.

pubmed: 19682929 doi: 10.1016/j.immuni.2009.08.001

Das Sarma J, Ciric B, Marek R, Sadhukhan S, Caruso ML, Shafagh J, et al. Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis. J Neuroinflammation. 2009;28(6):14.

doi: 10.1186/1742-2094-6-14

Kostic M, Zivkovic N, Cvetanovic A, Stojanovic I, Colic M. IL-17 signalling in astrocytes promotes glutamate excitotoxicity: Indications for the link between inflammatory and neurodegenerative events in multiple sclerosis. Mult Scler Relat Disord. 2017;11:12–7.

pubmed: 28104249 doi: 10.1016/j.msard.2016.11.006

von Banchet GS, Boettger MK, König C, Iwakura Y, Bräuer R, Schaible HG. Neuronal IL-17 receptor upregulates TRPV4 but not TRPV1 receptors in DRG neurons and mediates mechanical but not thermal hyperalgesia. Mol Cell Neurosci. 2013;52:152–60.

doi: 10.1016/j.mcn.2012.11.006

Meng X, Zhang Y, Lao L, Saito R, Li A, Bäckman CM, et al. Spinal interleukin-17 promotes thermal hyperalgesia and NMDA NR1 phosphorylation in an inflammatory pain rat model. Pain. 2013;154(2):294–305.

pubmed: 23246025 doi: 10.1016/j.pain.2012.10.022

Chen C, Itakura E, Nelson GM, Sheng M, Laurent P, Fenk LA, et al. IL-17 is a neuromodulator of Caenorhabditis elegans sensory responses. Nature. 2017;542(7639):43–8.

pubmed: 28099418 pmcid: 5503128 doi: 10.1038/nature20818

Luo H, Liu HZ, Zhang WW, Matsuda M, Lv N, Chen G, et al. Interleukin-17 regulates neuron-glial communications, synaptic transmission, and neuropathic pain after chemotherapy. Cell Rep. 2019;29(8):2384-2397.e5.

pubmed: 31747607 doi: 10.1016/j.celrep.2019.10.085

Di Filippo M, Mancini A, Bellingacci L, Gaetani L, Mazzocchetti P, Zelante T, et al. Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis. Cell Rep. 2021;37(10):110094.

pubmed: 34879272 doi: 10.1016/j.celrep.2021.110094

Dikmen HO, Hemmerich M, Lewen A, Hollnagel JO, Chausse B, Kann O. GM-CSF induces noninflammatory proliferation of microglia and disturbs electrical neuronal network rhythms in situ. J Neuroinflammation. 2020;17(1):235.

pubmed: 32782006 pmcid: 7418331 doi: 10.1186/s12974-020-01903-4

Waisman A, Hauptmann J, Regen T. The role of IL-17 in CNS diseases. Acta Neuropathol. 2015;129(5):625–37.

pubmed: 25716179 doi: 10.1007/s00401-015-1402-7

Pierson ER, Goverman JM. GM-CSF is not essential for experimental autoimmune encephalomyelitis but promotes brain-targeted disease. JCI Insight. 2017;2(7): e92362.

pubmed: 28405624 pmcid: 5374070 doi: 10.1172/jci.insight.92362

Medelin M, Giacco V, Aldinucci A, Castronovo G, Bonechi E, Sibilla A, et al. Bridging pro-inflammatory signals, synaptic transmission and protection in spinal explants in vitro. Mol Brain. 2018;11(1):3.

pubmed: 29334986 pmcid: 5769440 doi: 10.1186/s13041-018-0347-x

Lo Sasso B, Agnello L, Bivona G, Bellia C, Ciaccio M. Cerebrospinal fluid analysis in multiple sclerosis diagnosis: an update. Medicina. 2019;55(6):245. https://doi.org/10.3390/medicina55060245 .

doi: 10.3390/medicina55060245 pubmed: 31167509 pmcid: 6630948

Zrzavy T, Höftberger R, Wimmer I, Berger T, Rommer P, Macher S. Longitudinal CSF findings in autoimmune encephalitis-a monocentric cohort study. Front Immunol. 2021;22(12):646940. https://doi.org/10.3389/fimmu.2021.646940 .

doi: 10.3389/fimmu.2021.646940

Jarius S, König FB, Metz I, Ruprecht K, Paul F, Brück W, et al. Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis. J Neuroinflammation. 2017;14(1):171. https://doi.org/10.1186/s12974-017-0929-z .

doi: 10.1186/s12974-017-0929-z pubmed: 28851393 pmcid: 5576197

Saruhan-Direskeneli G, Yentür SP, Mutlu M, Shugaiv E, Yesilot N, Kürtüncü M, et al. Intrathecal oligoclonal IgG bands are infrequently found in neuro-Behçet’s disease. Clin Exp Rheumatol. 2013;31(3 Suppl 77):25–7.

pubmed: 23558092

Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisakk P, Ransohoff RM, et al. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain. 2006;129(Pt 1):200–11.

pubmed: 16280350 doi: 10.1093/brain/awh680

Khademi M, Kockum I, Andersson ML, Iacobaeus E, Brundin L, Sellebjerg F, et al. Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course. Mult Scler. 2011;17(3):335–43. https://doi.org/10.1177/1352458510389102 .

doi: 10.1177/1352458510389102 pubmed: 21135023

DiSano KD, Gilli F, Pachner AR. Intrathecally produced CXCL13: a predictive biomarker in multiple sclerosis. Mult Scler J Exp Transl Clin. 2020;6(4):2055217320981396. https://doi.org/10.1177/2055217320981396 .

doi: 10.1177/2055217320981396 pubmed: 33403120 pmcid: 7747124

Kothur K, Wienholt L, Brilot F, Dale RC. CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: a systematic review. Cytokine. 2016;77:227–37.

pubmed: 26463515 doi: 10.1016/j.cyto.2015.10.001

Dhaiban S, Al-Ani M, Elemam NM, Maghazachi AA. Targeting chemokines and chemokine receptors in multiple sclerosis and experimental autoimmune encephalomyelitis. J Inflamm Res. 2020;29(13):619–33. https://doi.org/10.2147/JIR.S270872 .

doi: 10.2147/JIR.S270872

D’Ambrosio D, Iellem A, Bonecchi R, Mazzeo D, Sozzani S, Mantovani A, et al. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol. 1998;161(10):5111–5.

pubmed: 9820476 doi: 10.4049/jimmunol.161.10.5111

Poppensieker K, Otte DM, Schürmann B, Limmer A, Dresing P, Drews E, et al. CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells. Proc Natl Acad Sci USA. 2012;109(10):3897–902. https://doi.org/10.1073/pnas.1114153109 .

doi: 10.1073/pnas.1114153109 pubmed: 22355103 pmcid: 3309768

Khaibullin T, Ivanova V, Martynova E, Cherepnev G, Khabirov F, Granatov E, et al. Elevated levels of proinflammatory cytokines in cerebrospinal fluid of multiple sclerosis patients. Front Immunol. 2017;8:531. https://doi.org/10.3389/fimmu.2017.00531 .

doi: 10.3389/fimmu.2017.00531 pubmed: 28572801 pmcid: 5435759

Kuhlmann T, Ludwin S, Prat A, Antel J, Bruck W, Lassmann H. An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol. 2017;133:13–24. https://doi.org/10.1007/s00401-016-1653-y .

doi: 10.1007/s00401-016-1653-y pubmed: 27988845

Peferoen LA, Vogel DY, Ummenthum K, Breur M, Heijnen PD, Gerritsen WH, et al. Activation status of human microglia is dependent on lesion formation stage and remyelination in multiple sclerosis. J Neuropathol Exp Neurol. 2015;74:48–63. https://doi.org/10.1097/NEN.0000000000000149 .

doi: 10.1097/NEN.0000000000000149 pubmed: 25470347

Donninelli G, Studer V, Brambilla L, Zecca C, Peluso D, Laroni A, Michelis D, Mantegazza R, Confalonieri P, Volpe E. Immune soluble factors in the cerebrospinal fluid of progressive multiple sclerosis patients segregate into two groups. Front Immunol. 2021;10(12):633167. https://doi.org/10.3389/fimmu.2021.633167 .

doi: 10.3389/fimmu.2021.633167

Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J Neuroimmunol. 1998;84(2):238–49. https://doi.org/10.1016/s0165-5728(97)00208-7 .

doi: 10.1016/s0165-5728(97)00208-7 pubmed: 9628469

Mahad DJ, Howell SJ, Woodroofe MN. Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2002;72(4):498–502. https://doi.org/10.1136/jnnp.72.4.498 .

doi: 10.1136/jnnp.72.4.498 pubmed: 11909910 pmcid: 1737819

Izikson L, Klein RS, Charo IF, Weiner HL, Luster AD. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med. 2000;192(7):1075–80. https://doi.org/10.1084/jem.192.7.1075 .

doi: 10.1084/jem.192.7.1075 pubmed: 11015448 pmcid: 2193310

Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med. 2001;193(6):713–26. https://doi.org/10.1084/jem.193.6.713 .

doi: 10.1084/jem.193.6.713 pubmed: 11257138 pmcid: 2193420

Franciotta D, Martino G, Zardini E, Furlan R, Bergamaschi R, Andreoni L, et al. Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies. J Neuroimmunol. 2001;115(1–2):192–8. https://doi.org/10.1016/s0165-5728(01)00261-2 .

doi: 10.1016/s0165-5728(01)00261-2 pubmed: 11282170

Sørensen TL, Ransohoff RM, Strieter RM, Sellebjerg F. Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis. Eur J Neurol. 2004;11(7):445–9. https://doi.org/10.1111/j.1468-1331.2004.00796.x .

doi: 10.1111/j.1468-1331.2004.00796.x pubmed: 15257681

de Morales JMGR, Puig L, Daudén E, Cañete JD, Pablos JL, Martín AO, et al. Critical role of interleukin (IL)-17 in inflammatory and immune disorders: an updated review of the evidence focusing in controversies. Autoimmun Rev. 2020;19(1):102429. https://doi.org/10.1016/j.autrev.2019.102429 .

doi: 10.1016/j.autrev.2019.102429

Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology. 2010;129:311–21. https://doi.org/10.1111/j.1365-2567.2009.03240.x .

doi: 10.1111/j.1365-2567.2009.03240.x pubmed: 20409152 pmcid: 2826676

Milovanovic J, Arsenijevic A, Stojanovic B, Kanjevac T, Arsenijevic D, Radosavljevic G, et al. Interleukin-17 in chronic inflammatory neurological diseases. Front Immunol. 2020;3(11):947. https://doi.org/10.3389/fimmu.2020.00947 .

doi: 10.3389/fimmu.2020.00947

Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest. 2006;116(5):1218–22. https://doi.org/10.1172/JCI28508 .

doi: 10.1172/JCI28508 pubmed: 16670765 pmcid: 1451213

Lovett-Racke AE, Racke MK. Chapter 5-role of IL-12/IL-23 in the pathogenesis of multiple sclerosis. In: Minagar A, editor. Neuroinflammation. 2nd ed. Cambridge: Academic Press; 2018. p. 115–39. https://doi.org/10.1016/B978-0-12-811709-5.00005-3 .

doi: 10.1016/B978-0-12-811709-5.00005-3

Matusevicius D, Kivisäkk P, He B, Kostulas N, Ozenci V, Fredrikson S, et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler. 1999;5(2):101–4. https://doi.org/10.1177/135245859900500206 .

doi: 10.1177/135245859900500206 pubmed: 10335518

Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 2002;8(5):500–8. https://doi.org/10.1038/nm0502-500 .

doi: 10.1038/nm0502-500 pubmed: 11984595

Brucklacher-Waldert V, Sturner K, Kolster M, Wolthausen J, Tolosa E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain. 2009;132:3329–41.

pubmed: 19933767 doi: 10.1093/brain/awp289

Núñez C, Dema B, Cénit MC, Polanco I, Maluenda C, Arroyo R, et al. IL23R: a susceptibility locus for celiac disease and multiple sclerosis? Genes Immun. 2008;9(4):289–93. https://doi.org/10.1038/gene.2008.16 .

doi: 10.1038/gene.2008.16 pubmed: 18368064

Segal BM, Constantinescu CS, Raychaudhuri A, Kim L, Fidelus-Gort R, Kasper LH, Ustekinumab MS Investigators. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol. 2008;7(9):796–804. https://doi.org/10.1016/S1474-4422(08)70173-X .

doi: 10.1016/S1474-4422(08)70173-X pubmed: 18703004

Panitch HS, Hirsch RL, Schindler J, Johnson KP. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology. 1987;37(7):1097–102. https://doi.org/10.1212/wnl.37.7.1097 .

doi: 10.1212/wnl.37.7.1097 pubmed: 3110648

Furlan R, Brambilla E, Ruffini F, Poliani PL, Bergami A, Marconi PC, et al. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J Immunol. 2001;167(3):1821–9. https://doi.org/10.4049/jimmunol.167.3.1821 .

doi: 10.4049/jimmunol.167.3.1821 pubmed: 11466408

Lees JR, Cross AH. A little stress is good: IFN-gamma, demyelination, and multiple sclerosis. J Clin Invest. 2007;117(2):297–9. https://doi.org/10.1172/JCI31254 .

doi: 10.1172/JCI31254 pubmed: 17273549 pmcid: 1783822

Lin W, Bailey SL, Ho H, Harding HP, Ron D, Miller SD, et al. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. J Clin Invest. 2007;117(2):448–56. https://doi.org/10.1172/JCI29571 .

doi: 10.1172/JCI29571 pubmed: 17273557 pmcid: 1783809

Shi Y, Liu CH, Roberts AI, Das J, Xu G, Ren G, et al. Granulocyte-macrophage colony-stimulating factor (gm-csf) and T-cell responses: What we do and don’t know. Cell Res. 2006;16:126–33. https://doi.org/10.1038/sj.cr.7310017 .

doi: 10.1038/sj.cr.7310017 pubmed: 16474424

Rasouli J, Ciric B, Imitola J, Gonnella P, Hwang D, Mahajan K, et al. Expression of gm-csf in t cells is increased in multiple sclerosis and suppressed by ifn-beta therapy. J Immunol. 2015;194:5085–93. https://doi.org/10.4049/jimmunol.1403243 .

doi: 10.4049/jimmunol.1403243 pubmed: 25917097

Constantinescu CS, Asher A, Fryze W, Kozubski W, Wagner F, Aram J, et al. Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2015;2(4): e117. https://doi.org/10.1212/NXI.0000000000000117 .

doi: 10.1212/NXI.0000000000000117 pubmed: 26185773 pmcid: 4442097

Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7(310):310ra166. https://doi.org/10.1126/scitranslmed.aab4176 .

doi: 10.1126/scitranslmed.aab4176 pubmed: 26491076

Ireland SJ, Monson NL, Davis LS. Seeking balance: potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10. Cytokine. 2015;73(2):236–44. https://doi.org/10.1016/j.cyto.2015.01.009 .

doi: 10.1016/j.cyto.2015.01.009 pubmed: 25794663 pmcid: 4437890

Frei K, Fredrikson S, Fontana A, Link H. Interleukin-6 is elevated in plasma in multiple sclerosis. J Neuroimmunol. 1991;31(2):147–53. https://doi.org/10.1016/0165-5728(91)90020-8 .

doi: 10.1016/0165-5728(91)90020-8 pubmed: 1991821

Stampanoni Bassi M, Iezzi E, Drulovic J, Pekmezovic T, Gilio L, Furlan R, et al. IL-6 in the cerebrospinal fluid signals disease activity in multiple sclerosis. Front Cell Neurosci. 2020;23(14):120. https://doi.org/10.3389/fncel.2020.00120 .

doi: 10.3389/fncel.2020.00120

Aharoni R. The mechanism of action of glatiramer acetate in multiple sclerosis and beyond. Autoimmun Rev. 2013;12(5):543–53.

pubmed: 23051633 doi: 10.1016/j.autrev.2012.09.005

Netea MG, van de Veerdonk FL, van der Meer JW, Dinarello CA, Joosten LA. Inflammasome-independent regulation of IL-1-family cytokines. Annu Rev Immunol. 2015;33:49–77.

pubmed: 25493334 doi: 10.1146/annurev-immunol-032414-112306

Schiffenbauer J, Streit WJ, Butfiloski E, LaBow M, Edwards C 3rd, Moldawer LL. The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor. Clin Immunol. 2000;95:117–23.

pubmed: 10779405 doi: 10.1006/clim.2000.4851

Levesque SA, Pare A, Mailhot B, Bellver-Landete V, Kebir H, Lecuyer MA, et al. Myeloid cell transmigration across the CNS vasculature triggers IL-1beta-driven neuroinflammation during autoimmune encephalomyelitis in mice. J Exp Med. 2016;213:929–49.

pubmed: 27139491 pmcid: 4886360 doi: 10.1084/jem.20151437

Seppi D, Puthenparampil M, Federle L, Ruggero S, Toffanin E, Rinaldi F, et al. Cerebrospinal fluid IL-1beta correlates with cortical pathology load in multiple sclerosis at clinical onset. J Neuroimmunol. 2014;270:56–60.

pubmed: 24657029 doi: 10.1016/j.jneuroim.2014.02.014

Rossi S, Studer V, Motta C, Germani G, Macchiarulo G, Buttari F, et al. Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis. J Neuroinflammation. 2014;11:32.

pubmed: 24548694 pmcid: 3975953 doi: 10.1186/1742-2094-11-32

Lin CC, Edelson BT. New insights into the role of IL-1β in experimental autoimmune encephalomyelitis and multiple sclerosis. J Immunol. 2017;198(12):4553–60. https://doi.org/10.4049/jimmunol.1700263 .

doi: 10.4049/jimmunol.1700263 pubmed: 28583987

Gough P, Myles IA. Tumor necrosis factor receptors: pleiotropic signaling complexes and their differential effects. Front Immunol. 2020;25(11):585880. https://doi.org/10.3389/fimmu.2020.585880 .

doi: 10.3389/fimmu.2020.585880

Kemanetzoglou E, Andreadou E. CNS demyelination with TNF-α blockers. Curr Neurol Neurosci Rep. 2017;17:36.

pubmed: 28337644 pmcid: 5364240 doi: 10.1007/s11910-017-0742-1

Zahid M, Busmail A, Penumetcha SS, Ahluwalia S, Irfan R, Khan SA, et al. Tumor necrosis factor alpha blockade and multiple sclerosis: exploring new avenues. Cureus. 2021;13(10): e18847. https://doi.org/10.7759/cureus.18847 .

doi: 10.7759/cureus.18847 pubmed: 34804701 pmcid: 8597935

Yang S, Wang J, Brand DD, Zheng SG. Role of TNF-TNF receptor 2 signal in regulatory T cells and its therapeutic implications. Front Immunol. 2018;19(9):784. https://doi.org/10.3389/fimmu.2018.00784 .

doi: 10.3389/fimmu.2018.00784

Fensterl V, Sen GC. Interferons and viral infections. BioFactors. 2009;35(1):14–20. https://doi.org/10.1002/biof.6 .

doi: 10.1002/biof.6 pubmed: 19319841

Teige I, Treschow A, Teige A, Mattsson R, Navikas V, Leanderson T, et al. IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J Immunol. 2003;170(9):4776–84. https://doi.org/10.4049/jimmunol.170.9.4776 .

doi: 10.4049/jimmunol.170.9.4776 pubmed: 12707359

Galligan CL, Pennell LM, Murooka TT, Baig E, Majchrzak-Kita B, Rahbar R, et al. Interferon-beta is a key regulator of proinflammatory events in experimental autoimmune encephalomyelitis. Mult Scler. 2010;16(12):1458–73. https://doi.org/10.1177/1352458510381259 .

doi: 10.1177/1352458510381259 pubmed: 20935030

Pennell LM, Fish EN. Interferon-β regulates dendritic cell activation and migration in experimental autoimmune encephalomyelitis. Immunology. 2017;152(3):439–50. https://doi.org/10.1111/imm.12781 .

doi: 10.1111/imm.12781 pubmed: 28646573 pmcid: 5629448

Wang D, Ghosh D, Islam SM, Moorman CD, Thomason AE, Wilkinson DS, et al. IFN-β facilitates neuroantigen-dependent induction of CD25+ FOXP3+ regulatory T cells that suppress experimental autoimmune encephalomyelitis. J Immunol. 2016;197(8):2992–3007. https://doi.org/10.4049/jimmunol.1500411 .

doi: 10.4049/jimmunol.1500411 pubmed: 27619998

Palle P, Monaghan KL, Milne SM, Wan ECK. Cytokine signaling in multiple sclerosis and its therapeutic applications. Med Sci. 2017;5(4):23. https://doi.org/10.3390/medsci5040023 .

doi: 10.3390/medsci5040023

Filipi M, Jack S. Interferons in the treatment of multiple sclerosis: a clinical efficacy, safety, and tolerability update. Int J MS Care. 2020;22(4):165–72. https://doi.org/10.7224/1537-2073.2018-063 .

doi: 10.7224/1537-2073.2018-063 pubmed: 32863784

D’Angelo C, Reale M, Costantini E, Di Nicola M, Porfilio I, de Andrés C, et al. Profiling of canonical and non-traditional cytokine levels in interferon-β-treated relapsing-remitting-multiple sclerosis patients. Front Immunol. 2018;4(9):1240. https://doi.org/10.3389/fimmu.2018.01240 .

doi: 10.3389/fimmu.2018.01240

Zhang L, Yuan S, Cheng G, Guo B. Type I IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammation. PLoS ONE. 2011;6(12): e28432. https://doi.org/10.1371/journal.pone.0028432 .

doi: 10.1371/journal.pone.0028432 pubmed: 22163016 pmcid: 3232207

Kubo M, Motomura Y. Transcriptional regulation of the anti-inflammatory cytokine IL-10 in acquired immune cells. Front Immunol. 2012;30(3):275. https://doi.org/10.3389/fimmu.2012.00275 .

doi: 10.3389/fimmu.2012.00275

Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA, Kuchroo VK. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol. 1998;161(7):3299–306.

pubmed: 9759845 doi: 10.4049/jimmunol.161.7.3299

Ozenci V, Kouwenhoven M, Huang YM, Xiao B, Kivisäkk P, Fredrikson S, et al. Multiple sclerosis: levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment. Scand J Immunol. 1999;49(5):554–61. https://doi.org/10.1046/j.1365-3083.1999.00546.x .

doi: 10.1046/j.1365-3083.1999.00546.x pubmed: 10320650

Carrieri PB, Ladogana P, Di Spigna G, de Leva MF, Petracca M, Montella S, et al. Interleukin-10 and interleukin-12 modulation in patients with relapsing-remitting multiple sclerosis on therapy with interferon-beta 1a: differences in responders and non responders. Immunopharmacol Immunotoxicol. 2008;30(4):1–9. https://doi.org/10.1080/08923970802302753 .

doi: 10.1080/08923970802302753 pubmed: 18686100

Gilio L, Buttari F, Pavone L, Iezzi E, Galifi G, Dolcetti E, et al. Fatigue in multiple sclerosis is associated with reduced expression of interleukin-10 and worse prospective disease activity. Biomedicines. 2022;10(9):2058. https://doi.org/10.3390/biomedicines10092058 .

doi: 10.3390/biomedicines10092058 pubmed: 36140159 pmcid: 9495727

Streeter HB, Rigden R, Martin KF, Scolding NJ, Wraith DC. Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS. Neurol Neuroimmunol Neuroinflamm. 2015;2(3): e93. https://doi.org/10.1212/NXI.0000000000000093 .

doi: 10.1212/NXI.0000000000000093 pubmed: 25798453 pmcid: 4360798

Chataway J, Martin K, Barrell K, Sharrack B, Stolt P, Wraith DC, et al. Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis. Neurology. 2018;90(11):e955–62. https://doi.org/10.1212/WNL.0000000000005118 .

doi: 10.1212/WNL.0000000000005118 pubmed: 29467307

Paul WE, Zhu J. How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol. 2010;10(4):225–35. https://doi.org/10.1038/nri2735 .

doi: 10.1038/nri2735 pubmed: 20336151 pmcid: 3496776

Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Köhler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature. 1993;362(6417):245–8. https://doi.org/10.1038/362245a0 .

doi: 10.1038/362245a0 pubmed: 8384701

Falcone M, Rajan AJ, Bloom BR, Brosnan CF. A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice. J Immunol. 1998;160(10):4822–30.

pubmed: 9590229 doi: 10.4049/jimmunol.160.10.4822

Liblau R, Steinman L, Brocke S. Experimental autoimmune encephalomyelitis in IL-4-deficient mice. Int Immunol. 1997;9(5):799–803. https://doi.org/10.1093/intimm/9.5.799 .

doi: 10.1093/intimm/9.5.799 pubmed: 9184926

Urcelay E, Santiago JL, Mas A, Martínez A, de Las HV, Arroyo R, et al. Role of interleukin 4 in Spanish multiple sclerosis patients. J Neuroimmunol. 2005;168(1–2):164–7. https://doi.org/10.1016/j.jneuroim.2005.07.004 .

doi: 10.1016/j.jneuroim.2005.07.004 pubmed: 16169606

Tahani S, Dehghani L, Jahanbani-Ardakani H, Shaygannejad V, Fazli A, Hamidavi A, et al. Elevated serum level of IL-4 in neuromyelitis optica and multiple sclerosis patients. J Immunoassay Immunochem. 2019;40(5):555–63. https://doi.org/10.1080/15321819.2019.1655649 .

doi: 10.1080/15321819.2019.1655649 pubmed: 31422745

Chan AH, Schroder K. Inflammasome signaling and regulation of interleukin-1 family cytokines. J Exp Med. 2020;217(1): e20190314. https://doi.org/10.1084/jem.20190314 .

doi: 10.1084/jem.20190314 pubmed: 31611248

Kaufmann M, Evans H, Schaupp AL, Engler JB, Kaur G, Willing A, et al. Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis. Med. 2021;2(3):296-312.e8. https://doi.org/10.1016/j.medj.2021.01.006 .

doi: 10.1016/j.medj.2021.01.006 pubmed: 33748804

Mueller SN, Mackay LK. Tissue-resident memory T cells: local specialists in immune defence. Nat Rev Immunol. 2016;16(2):79–89. https://doi.org/10.1038/nri.2015.3 .

doi: 10.1038/nri.2015.3 pubmed: 26688350

Smolders J, van Luijn MM, Hsiao CC, Hamann J. T-cell surveillance of the human brain in health and multiple sclerosis. Semin Immunopathol. 2022;44(6):855–67. https://doi.org/10.1007/s00281-022-00926-8 .

doi: 10.1007/s00281-022-00926-8 pubmed: 35364699 pmcid: 9708786

The brain cytokine orchestra in multiple sclerosis: from neuroinflammation to synaptopathology.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Pagination

Subventions

Informations de copyright

Références

Auteurs

Roberta Amoriello (R)

Christian Memo (C)

Laura Ballerini (L)

Clara Ballerini (C)

Classifications MeSH